Premier Partners
Seoul · Series B · 40 people tracked
Team · 40 people
from the firm's websiteJoined Premier Partners in 2010 and leads growth equity and buyout investments across diverse industries as head of PE operations. Holds a degree in aerospace engineering from Seoul National University and an MBA from University of Oxford.
Co-founder of Premier Partners in 2005 with extensive experience in semiconductor investment and corporate venture at Samsung Electronics, InterVest, and Hyundai Technology Investment. Holds an electrical engineering degree from Hanyang University and completed an AMP program at KAIST.
Joined Premier Partners in 2015 focusing on fintech, shared mobility, and consumer sector investments. Holds an MBA from Kellogg School and professional certifications including CPA and CFA.
Joined Premier Partners in 2018 focusing on biotech and healthcare investments. Previously led new drug licensing and alliance work at Hanmi Pharmaceuticals. Holds an MBA from MIT Sloan School.
Joined Premier Partners in 2007 and focuses on ICT, mobile, and healthcare investments. Previously worked at SK Telecom and Andersen Consulting. Holds an MBA in management engineering from Stanford University.
Joined Premier Partners in 2013 focusing on acquisition transactions for mid-sized companies. Previously worked at Samil PwC and KUDOS, and served as CFO at portfolio company Trinity.
Joined Premier Partners in 2016 focusing on brand, medical devices, and manufacturing investments. Holds an MBA from London Business School.
Joined Premier Partners in 2016 overseeing fund operations. Previously worked at Eegun Industry, Samguang Glass, and Dongu Biotech. Successfully led an IPO project at Max ICS.
Joined Premier Partners in 2014 with expertise in growth equity and buyout investments in software, consumer goods, and ecommerce. Holds a master's degree in physics from Korea University.
Joined Premier Partners in 2025 with diverse industry investment experience. Previously worked at UCK Partners, Post Capital, CIP Capital, and Citigroup IB.
Joined Premier Partners in 2019 overseeing risk management operations. Previously served as CEO and CFO at CDNetworks and worked at Hyundai Technology Investment.
Joined Premier Partners in 2016 focusing on biotech and materials investments. Holds advanced degrees from University of Michigan and University of Cambridge, including a PhD in polymer engineering and an MBA.
Joined Premier Partners in 2015 focusing on mobile/online IT services, content, and platform investments. Holds an MBA from MIT Sloan School.
Joined Premier Partners in 2015 focusing on technology-based IT companies and healthcare investments. Previously worked in software development at Infinite Healthcare, product strategy at IBM, and business planning at Samsung Medison.
Joined Premier Partners in 2021 reviewing buyout and growth capital investments. Previously worked at Samjong KPMG Deal Advisory and Truestone Asset Management.
Joined Premier Partners in 2018 reviewing buyout and growth capital investments. Previously worked as CPA in M&A advisory at Deloitte Anjin.
Joined Premier Partners in 2017 focusing on platform, IT, and software investments. Previously worked at Doosan Heavy Industries and Solborn Investment.
Joined Premier Partners in 2022 focusing on IT and deep tech investments. Previously worked on computer vision technology at Samsung Electronics, mobile wallet product at LoopPay, and M&A at Samsung Next. Holds an MBA from Harvard Business School.
Joined Premier Partners in 2024 focusing on materials, components, equipment, and deep tech investments. Previously worked at KAIST and LG Innotek as researcher, and led semiconductor advanced process technology development at Samsung Electronics.
Joined Premier Partners in 2024 focusing on biotech healthcare and medical device investments. Previously worked in strategic investment at Il-dong Holdings and held industry positions at Otsuka Korea and Roche. Founded online pharmacy service SoulMedi.
Joined Premier Partners in 2022 reviewing buyout and growth capital investments. Previously worked at Samjong KPMG Deal Advisory, Metanet, and AT Kearney.
Joined Premier Partners in 2024 reviewing buyout and growth capital investments. Previously worked at SK Square, Mirae Asset Venture Investment, Samsung Electronics semiconductor research, and Dongjin Semichem.
Joined Premier Partners in 2014 focusing on fintech, media content, and IT service investments. Previously worked as a financial and M&A specialist attorney at Chungjeong Law Firm.
Joined Premier Partners in 2020 focusing on biotech and pharmaceutical investments. Previously worked on anticancer drug clinical development strategies at Hanmi Pharmaceuticals and Chong Kun Dang.
Joined Premier Partners in 2008 overseeing LP management and fund operations, and from 2018 overseeing risk management. Previously worked 18 years at KTB Network in sales management and audit.
Joined Premier Partners in 2023 focusing on biotech and AI healthcare investments. Previously worked as data scientist at UNC Medicine. Holds degrees in statistics and environmental science from Dartmouth College.
Joined Premier Partners in 2026 focusing on biotech healthcare investments. Previously worked on global new drug licensing and strategic investment at Hanmi Pharmaceuticals.
Joined Premier Partners in 2026 reviewing buyout and growth capital investments. Previously worked as consultant at Bain & Company. Holds a pharmacy degree and pharmacist license.
Joined Premier Partners in 2025 handling fund operations. Previously worked in financial accounting and disclosure at Samsung Futures and BNK Investment Securities.
Joined Premier Partners in 2020 overseeing compliance and legal matters. Previously worked as head of legal strategy at Toolgen. Holds attorney and patent attorney licenses.
Joined Premier Partners in 2022 overseeing fund management. Previously worked on startup acceleration and global collaboration networks at Gyeonggi Creative Economy Innovation Center.
Co-founder of Premier Partners in 2005 and pioneering venture capitalist beginning in 1981 at KTB Network. Previously served as CIO at Hyundai Technology Investment and CEO at InterVest. Holds an MBA from Sogang University.
Joined Premier Partners in 2021 overseeing fund management. Previously worked in finance and strategic planning at Five Brothers Korea and Humapp Content, and in fund management at CKD Venture Investment.
Joined Premier Partners in 2018 handling fund management operations. Previously worked at Capstone Partners in fund management.
Joined Premier Partners in 2023 handling general affairs. Holds a degree in airline services from Daelim University.
Joined Premier Partners in 2013 overseeing fund management. Holds a degree in economics from Hanyang University.
Joined Premier Partners in 2025 overseeing compliance and legal matters. Previously worked at Kearney, McKinsey & Company, Pariscraison, and Sejong Law Firm ESG Center.
Joined Premier Partners in 2019 overseeing fund management. Previously worked at Samsung Venture Investment.
Joined Premier Partners in 2019 overseeing fund management. Holds a degree in economics from Sangmyung University.
Joined Premier Partners in 2025 handling fund management operations. Previously worked in fund management at Ajou IB Investment and SL Investment.
Investments · showing 60 of 177
founders shown can be your intro pathFrequently asked questions
- What stage does Premier Partners invest at?
- Premier Partners invests at the Series B stage.
- Where is Premier Partners located?
- Premier Partners is headquartered in Seoul, KR.
Similar investors
3TS Capital is a technology investment firm with over 25 years of experience managing multiple fund generations. The firm partners with exceptional founders to scale internationally, targeting high-growth SMEs that are either proven local leaders or innovative global challengers.
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
83North is a lean venture capital partnership of four equal general partners that has operated for 19 years. The firm invests globally across the US, Europe, and Israel, and in 2025 raised what it describes as its final fund, shifting focus toward selectively pursuing new opportunities while supporting existing portfolio companies.